Lienlaf et al. provided evidence that HDAC6 plays a role in the body's defence against tumours in melanoma by affecting the STAT3-PD-L1 pathway [121], this discovery was further supported by Keremu et al. in their study on osteosarcomas [120]. Here, HDAC6 is linked to neoplasm.